Chemed Corporation (CHE)
| Market Cap | 7.44B |
| Revenue (ttm) | 2.13B |
| Net Income (ttm) | 307.68M |
| Shares Out | 15.40M |
| EPS (ttm) | 19.06 |
| PE Ratio | 25.36 |
| Forward PE | 25.45 |
| Dividend | $1.40 (0.29%) |
| Ex-Dividend Date | Nov 12, 2021 |
| Volume | 59,407 |
| Open | 503.92 |
| Previous Close | 498.97 |
| Day's Range | 482.76 - 499.00 |
| 52-Week Range | 403.00 - 560.00 |
| Beta | 0.46 |
| Analysts | Strong Buy |
| Price Target | 576.00 (+19.2%) |
| Earnings Date | Oct 28, 2021 |
About CHE
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in...
Financial Performance
In 2020, Chemed's revenue was $2.08 billion, an increase of 7.27% compared to the previous year's $1.94 billion. Earnings were $319.47 million, an increase of 45.26%.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for Chemed stock is "Strong Buy." The 12-month stock price forecast is 576.00, which is an increase of 19.18% from the latest price.
News
Here's Why You Should Add Chemed (CHE) to Your Portfolio Now
Robust performance across the Roto-Rooter segment and sequential growth in VITAS admissions are driving the top line for Chemed (CHE).
Chemed Corporation's Board of Directors Authorizes an Additional $300 Million for Stock Repurchase
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing sha...
Chemed Corporation Declares Quarterly Dividend of 36 Cents
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 36-cents per share on the Company's capital stock, payabl...
Chemed Corporation to Present at the 2021 Credit Suisse Virtual Healthcare Conference
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Credit Suisse 30th Annual Virtual Healthcare Conference on Wednesday, November 10, 2...
Chemed (CHE) Q3 Earnings Beat Estimates, Full-Year EPS View Up
Chemed (CHE) reports better-than-expected earnings and revenues in the third-quarter 2021, with a solid performance by the Roto-Rooter segment driving the top line.
Chemed (CHE) Q3 Earnings and Revenues Top Estimates
Chemed (CHE) delivered earnings and revenue surprises of 13.45% and 1.22%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Chemed Reports Third-Quarter 2021 Results - Full-Year 2021 Earnings Guidance Increased
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the...
Earnings Preview: Chemed (CHE) Q3 Earnings Expected to Decline
Chemed (CHE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemed To Report Third-Quarter 2021 Earnings October 28, Related Conference Call To Be Held On October 29
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended September 30, 2021, on Thursday, October 28, 2021, following...
Some Easy-to-Grasp Gimmicks to Gauge Management Compensation
Stock investing involves agency risk, as outside investors essentially delegate their capital to corporate executives to generate business returns without active participation in the management.
Here's Why Chemed (CHE) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Chemed (CHE) Moves to Buy: Rationale Behind the Upgrade
Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Chemed (CHE) Up 1.9% Since Last Earnings Report: Can It Continue?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
Chemed (CHE) Upgraded to Buy: Here's Why
Chemed (CHE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
5 Stocks to Buy as Analysts Initiate Coverage
Increased analyst coverage over the past few weeks might lead to solid price appreciation for stocks like CATY, BIO, CHE, MTLS and ABR.
Here's Why You Should Add Chemed (CHE) to Your Portfolio Now
Investors are optimistic about Chemed (CHE) on strong segmental growth and raised Roto-Rooter and earnings guidance for 2021.
Chemed Corporation Declares Quarterly Dividend of 36 Cents
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 36-cents per share on the Company's capital stock, payabl...
Chemed (CHE) Q2 Earnings & Revenues Top Estimates, Margins Up
Chemed (CHE) reports better-than-expected earnings and revenues with strong Roto-Rooter segment performance driving the top line in second-quarter 2021.
Chemed (CHE) Q2 Earnings and Revenues Surpass Estimates
Chemed (CHE) delivered earnings and revenue surprises of 3.37% and 0.75%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Chemed: Q2 Earnings Insights
Shares of Chemed (NYSE:CHE) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 4.31% over the past year to $4.60, which beat the esti...
Chemed Reports Second-Quarter 2021 Results - Full-Year 2021 Guidance Increased
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation Second-Quarter 2021 Earnings
Chemed (CHE) Earnings Expected to Grow: Should You Buy?
Chemed (CHE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemed To Report Second-Quarter 2021 Earnings July 27, Related Conference Call To Be Held On July 28
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the second quarter ended June 30, 2021, on Tuesday, July 27, 2021, following the clo...
Why Is Chemed (CHE) Up 4.7% Since Last Earnings Report?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
Chemed Corporation to Present at the Jefferies 2021 Virtual Healthcare Conference
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Jefferies 2021 Virtual Healthcare Conference on Wednesday, June 2, 2021, at approxim...